Absence of cancer diagnosis and treatment in elderly medicaid-insured nursing home residents

Journal of the National Cancer Institute

Volumn 100, Issue 1, 2008, Pages 21-31

  Bradley, Cathy J ^a,b   Clement, Jan P ^a   Lin, Chunchieh ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

AFRICAN AMERICAN; AGE; AGED; ARTICLE; BLADDER CANCER; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER LOCALIZATION; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER THERAPY; COLORECTAL CANCER; COMORBIDITY; CONFIDENCE INTERVAL; DEMOGRAPHY; DIGESTIVE SYSTEM CANCER; FEMALE; HOSPICE CARE; HUMAN; INCOME; LEUKEMIA; LOGISTIC REGRESSION ANALYSIS; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MEDICAID; NURSING HOME PATIENT; PANCREAS CANCER; PRIORITY JOURNAL; PROSTATE CANCER; RACE; RISK FACTOR; SEX; STATISTICAL ANALYSIS; CAUCASIAN; HOME FOR THE AGED; MEDICARE; METHODOLOGY; MORTALITY; NEOPLASM; NURSING HOME; PALLIATIVE THERAPY; REGISTER; RISK; RISK ASSESSMENT; STATISTICAL MODEL; STATISTICS; UNITED STATES; UTILIZATION REVIEW;

AFRICAN AMERICANS; AGE FACTORS; AGED; AGED, 80 AND OVER; COMORBIDITY; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HOMES FOR THE AGED; HOSPICE CARE; HUMANS; LOGISTIC MODELS; MALE; MEDICAID; MEDICARE; MICHIGAN; NEOPLASMS; NURSING HOMES; ODDS RATIO; PALLIATIVE CARE; REGISTRIES; RESEARCH DESIGN; RESIDENCE CHARACTERISTICS; RISK ASSESSMENT; RISK FACTORS; UNITED STATES;

EID: 38049179199     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/djm271     Document Type: Article

References (49)

1. Johnson V, Teno JM, Bourbonniere M, Mor V. Palliative care needs of cancer patients in U.S. nursing homes. J Palliat Med. 2005;8:273-279.
2. Albano J, Ward E, Jemal A, et al. Cancer mortality in the United States by education level and race. J Natl Cancer Inst. 2007;99:1384-1394.
3. Howard G, Anderson R, Russell G, Howard V, Burke G. Race, socioeconomic status, and cause-specific mortality. Ann Epidemiol. 2000;10:214-223.
4. Griggs J, Culakova E, Sorbero M, et al. Effect of patient socioeconomic status and body mass index on the quality of breast cancer adjuvant chemotherapy. J Clin Oncol. 2007;25:277-284.
5. Bradley C, Given C, Luo Z, Dahman B, Virnig B. Diagnosis of advanced cancer among elderly Medicare and Medicaid patients. Med Care. 2007;45:410-419.
6. Edwards B, Brown M, Wingo P, et al. Annual report to the nation on the status of cancer; 1975-2002, featuring population-based trends in cancer treatment. J Natl Cancer Inst. 2005;97:1407-1427.
7. Hoffman R, Harlan L, Klabunde K, et al. Racial differences in initial treatment for clinically localized prostate cancer. J Gen Intern Med. 2003;18:845-853.
8. Cartier C. From home to hospital and back again: economic restructuring, end of life, and the gendered problems of place-switching health services. Soc Sci Med. 2003;56:2289-2301.
9. Yancik R. Cancer burden in the aged: an epidemiological and demographic overview of cancer. Cancer. 1997;80:1261-1266.
10. Bourbonniere M, Cleave J. Cancer care in nursing homes. Semin Oncol Nurs. 2006;22:51-57.
11. Gagnon B, Mayo NE, Hanley J, MacDonald N. Pattern of care at the end of life: does age make a difference in what happens to women with breast cancer? J Clin Oncol. 2004;22:3458-3465.
12. Teno JM, Weitzen S, Fennell ML, et al. Dying trajectory in the last year of life: does cancer trajectory fit other diseases? J Palliat Med. 2001;4:457-464.
13. Li CI. Racial and ethnic disparities in breast cancer stage, treatment, and survival in the United States. Ethn Dis. 2005;15(2 suppl 2):S5-S9.
14. Madison T, Schottenfeld D, James SA, et al. Endometrial cancer: socioeconomic status and racial/ethnic differences in stage at diagnosis, treatment, and survival. Am J Public Health. 2004;12:2104-2111.
15. Joslyn SA, Foote ML, Nasseri K, et al. Racial and ethnic disparities in breast cancer rates by age: NAACCR Breast Cancer Project. Breast Cancer Res Treat. 2005;92:97-105.
16. Chang KJ, Parasher G, Christie C, et al. Risk of pancreatic adenocarcinoma: disparity between African Americans and other race/ethnic groups. Cancer. 2005;103(2):349-357.
17. Henson DE, Chu KC, Levine PH. Histologic grade, stage, and survival in breast carcinoma: comparison of African American and Caucasian women. Cancer. 2003;98(5):908-917.
18. Girvan-Oakley I, Kolonel LN, Gallahger RP, et al. State at diagnosis and survival in a multiethnic cohort. Am J Public Health. 2003;93(10):1753-1759.
19. Schwartz KL, Crossley-May H, Vigneau FD, et al. Race, socioeconomic status and stage at diagnosis for five common malignancies. Cancer Causes Control. 2003;14:761-766.
20. Farley TA, Flannery JT. Late-stage diagnosis of breast cancer in women of lower socioeconomic status: public health implications. Am J Public Health. 1989;79(11): 1508-1512.
21. Bradley CJ, Given CW, Roberts C. Race, socioeconomic status, and breast cancer treatment and survival. J Natl Cancer Inst. 2002;94(7):490-496.
22. Satariano WA, Ragland DR. The effect of comorbidity on 3-year survival of women with primary breast cancer. Ann Intern Med. 1994;120:104-110.
23. Vaeth PA, Satariano WA, Ragland DR. Limiting comorbid conditions and breast cancer stage at diagnosis. J Gerontol A Biol Sci Med Sci. 2000;55:M593-M600.
24. West DW, Satariano WA, Ragland DR, et al. Comorbidity and breast cancer survival: a comparison between black and white women. Ann Epidemiol. 1996;6:413-419.
25. Fleming S, Pursley H, Newman B, et al. Comorbidity as a predictor of stage of illness for patients with breast cancer. Med Care. 2005;42(2):132-140.
26. Gorin SS, Heck J, Albert S, et al. Treatment for breast cancer in patients with Alzheimer's disease. J Am Geriatr Soc. 2005;53(11)1897- 1904.
27. Gupta SK, Lamont EB. Patterns of presentation, diagnosis, and treatment in older patients with colon cancer and comorbid dementia. J Am Geriatr Soc. 2004;52:1681-1687.
28. Walter LC, Eng C, Covinsky K. Screening mammography for frail older women: what are the burdens? J Gen Intern Med. 2001;16:779-784.
29. Kaiser Family State Health Facts. http://www.statehealthfacts.org/ comparetable.jsp?ind=178&cat=4. Accessed December 3, 2007.
30. Kaiser Commission on Medicaid Facts. Medicaid and the Uninsured. Publication 4091-04. July 2005. http://www.st.org/medicaid/upload/4091- 04%20Final(v2).pdf. Accessed December 3, 2007.
31. Murray L, Shatto A. Dually eligible Medicare beneficiaries. Health Care Financ Rev. 1998;20(2):131-140.
32. Institute of Medicine. Improving the Quality of Long-term Care. Washington (DC): National Academy Press;2001.
33. U.S. General Accounting Office. Nursing Homes: Care Problems Persist Despite Federal and State Oversight. Report to the Special Committee on Aging, U.S. Senate. Publication GAO/HEHE-99-46. Washington (DC): U.S. General Accounting Office;1999.
34. National Cancer Institute. Staging: Questions and Answers. http://www.cancer.gov/cancertopics/factsheet/Detection/staging. Accessed December 3, 2007.
35. Bradley C, Given C, Luo Z, et al. Medicaid, Medicare, and state tumor registries: a linkage strategy. Med Decis Making. 2007;27(4): 352-363.
36. Breen N, Figueroa JB. Stage of breast and cervical cancer diagnosis in disadvantaged neighborhoods: a prevention policy perspective. Am J Prev Med. 1996;12(5):319-326.
37. Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol. 1992;45:613-619.
38. Klabunde CE, Potosky AL, Legler JM, et al. Development of a comorbidity index using physician claims data. J Clin Epidemiol. 2000;53:1258-1267.
39. Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373-383.
40. Froehner M, Koch R, Litz R, et al. Comparison of the American Society of Anesthesiologists physical status classification with the Charlson score as predictors of survival after radical prostatectomy. Urology. 2003;62:698-701.
41. Extermann M. Measuring comorbidity in older cancer patients. Eur J Cancer. 2000;36:453-471.
42. Casarett D, Karlawish J, Morales K, et al. Improving the use of hospice services in nursing homes: a randomized controlled trial. JAMA. 2005;294:211-217.
43. Baldwin LM, Dobie SA, Billingsley K, et al. Explaining black-white differences in receipt of recommended colon cancer treatment. J Natl Cancer Inst. 2005;97(16):1211-1220.
44. Demissie K, Oluwole O, Balasubramanian B, et al. Racial differences in the treatment of colorectal cancer: a comparison of surgical and radiation therapy between whites and blacks. Ann Epidemiol. 2004;14:215-221.
45. Bach P, Cramer L, Warren J, Begg C. Racial differences in the treatment of early stage lung cancer. N Engl J Med. 1999;241:1198-1205.
46. Mor V, Intrator O, Laliberte L. Factors affecting conversion rates to Medicaid among new admissions to nursing homes. Health Serv Res. 1993;28:1-25.
47. Keating N, Herrinton L, Zaslavsky A, et al. Variations in hospice use among cancer patients. J Natl Cancer Inst. 2006;98:1053-1059.
48. Capitaman J, Leutz W, Bishop C, Casler R. Long-Term Care Quality: Historical Overview and Current Initiatives. Washington (DC): National Commission for Quality Long-term Care, 2007. http://www. qualitylongtermcarecommission.org/reports.html. Accessed January 2007.
49. Lunney JR, Lynn J, Foley DJ, et al. Patterns of functional decline at the end of life. JAMA. 2003;289:2387-2392.